MRNA Falling wedge Anticipating breakout move after period of consolidation, followed by retest of upper trend line and push to highs
MRNA
MRNA going back to $120, entered downard channel trend!MRNA seems to have entered another downward channel trend.
Using the previous resistance on the last downward channel trend we can see it can act as a sort of support, the trend also made two other downward resistances as you can see on the chart.
This makes me to believe that this could go back down to $120 where it can make a double bottom which can be a great buying opportunity, but for now, I'm bearish.
MRNA formed a double bottomModerna seems to have made a double bottom, this could indicate some bullishness coming in and if it passes the previous resistance of around $135.50 then the next resistance comes at $145 so there is quite a way to go back up!
MRNA going back down to $120?As mentioned in my last analysis, Monday will be the deal-breaker for MRNA again, and it failed to hold that resistance.
Using historic data this will most likely drop down to $120 again before going back up to the $130s so this can be a great swing trade.
BUT! Watch out for support at $126, using the previous downward channel trend resistance this can act as support so watch out for that.
Reasons for bearishness:
-Historic data of the resistance and dip (influenced the most)
-EMA's crossing right now
-RSI was oversold
It's a clear bearish sign that probably won't last for long so look for a nice swing trade here.
(I am not a financial advisor)
MRNA jumps after hitting support, whats next?For this analysis, I am going to be using the same downward trend channel that I made on March 25th and it went exactly as expected. This recent spike might be coming to an end though due to being overbought on the RSI and close to hitting the resistance on the trend channel.
Although if it breaks through that resistance it can become support, keep an eye on MRNA. If it doesn't break through then it could go back to the $120s level.
MRNA broke through support (Next target $110?)I published multiple bearish analyses on MRNA since 145$, right now it broke through the support at $120 and if it doesnt recover today then it's most likely going to go to $110-$100.
Although if that doesn't hold it can go down to $75.
MRNA Moderna vs PFE Pfizer | Head and Shoulders patternIf you haven`t longed Moderna with me from here:
Then you should realize that the head an shoulders pattern on descending volume of a company that worth 53.402B, but has 747Mil negative earnings for 2020, may lead to $100 per share.
On the other hand, undervalued, it`s Pfizer , which has the same amazing results with the vaccine, lots of medicine in the portfolio, a market cap almost 4 times higher, 198.973B and positive earnings of 9.62Bil. The pay also great dividends, btw, 4.38% DIV YIELD on a decent 20.82 P/E ratio .
If you are interested to test some amazing BUY and SELL INDICATORS which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
MRNA on resistance lineMRNA seems to be on a resistance ($156.65), if it passes it then the next resistance is $158. If it doesnt pass it then it will most likely enter low 140s again.
MRNA Upside PotentialModerna has been forming a hidden bullish divergence for the past 5 months (clearly seen on the daily chart, will also post a screenshot in the comments). On the macro-level, we can see a pennant forming with strongly confirmed resistance and support. On the micro-level, we have a clear cup and handle, and currently the price seats at the support of the handle, in 3h demand, and also at a strong key level 135-136, that MRNA always reacted to in the past.
If Moderna confirms the cup and handle by breaking the resistance, would love to add to my long position. However, if it can not hold 135-136, will look to exit and reenter at the macro support ~129.
*The idea above is my own opinion and does not serve as any kind of investment advice. Please do your own due diligence.*
Battle of the mRNA vaccines.Just interesting that Moderna (MRNA) was taking off while Pfizer (PFE) was declining.
$mrna $nasdaqI was opened position and here at todays lows..!
you can see my short term PT..
138$
good luck!
Take a look MRNAWait for it, we are seeing strong pull back to 0.618 level, if pull back to 0.5 level there might be a chance to go long
RSI is signaling a good potential buy area, according to the historical comparison. let's see, let's see
Be aware this is not investment advice, for personal use only
OCGN injectedContinuation play here in my opinion. Can expect this to travel up to around 20$ in the next few weeks. Trade safe! This is a high risk pick...
Please like/share if you want to see more!
MRNA to 250 in MarMRNA could possibly reach as high as 250’s before or after the earnings report on 10 Mar.
Not only it may beat the earnings estimate, there are also quite positive news which may lead to explosive growth.
First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research
NEW YORK and LA JOLLA, CA—A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today. The vaccine showed success in stimulating production of rare immune cells needed to start the process of generating antibodies against the fast-mutating virus; the targeted response was detected in 97 percent of participants who received the vaccine.
…
The study sets the stage for additional clinical trials that will seek to refine and extend the approach—with the long-term goal of creating a safe and effective HIV vaccine. As a next step, IAVI and Scripps Research are partnering with the biotechnology company Moderna to develop and test an mRNA-based vaccine that harnesses the approach to produce the same beneficial immune cells. Using mRNA technology could significantly accelerate the pace of HIV vaccine development.
…
The strategy of targeting naïve B cells with specific properties is called “germline-targeting,” as these young B cells display antibodies encoded by unmutated, or “germline” genes. Researchers believe the approach could also be applied to vaccines for other challenging pathogens such as influenza, dengue, Zika, hepatitis C viruses and malaria.
Clean Setup in MRNAIt hasn't broken out yet, but MRNA looks poised to continue higher. I wouldn't mind a starter here because risk is so easy to manage. This name seems like it will be obvious in hindsight, but people overlook it now because they want the hot new stock. This technology is revolutionary and will become brand name. It doesn't have the upside that it once had, but that doesn't mean you shouldn't want to own it.
APT Squeeze Round 2Haven't shared a chart for this since June, but it's finally time.
- Biden presidency = continued demand for masks for the foreseeable future
- Premiums are still surprisingly cheap
- Only $250MM market cap, so a move to $100 isn't crazy at all (would barely put it over $1B)
- Clear trend break
- Makes vertical moves out of accumulation
KMPH goes to $15-20 off PDUFA hypeI am only playing the run up, but it has been said it is very likely FDA approves their drug.
My run up target before March 2 is $15-20.
Target price for Novavax..?Novavax is getting ready to test its all time high at 300, but it could go further.
On April 15th 2020, I made the first call on MRNA, NVAX, and INO, to be the companies which will produce COVID-19 vaccine.After 10 months 2 out of 3 have COVID-19 vaccine on the market!
Ever since MRNA has had 468% and NVAX made a decent 1240% gain just in 9 months
Don’t follow the INSIDERS, THEY KNOW NOTHING ABOUT STOCKS!While MRNA has had a great year and rewarded its investors by decent +1500% profit in a year!
Checking the fact that insiders have sold 29,554,776 share in 300 trades last year and bought 310,142 shares will shock you..!
Interestingly, they bought 0 share in last 3 months, when they have had the result of their COVID-19 vaccine which is 95% effective..! No need to say that MRNA stock had almost 180% gain ever since !
MRNA, U Shape recoveryNASDAQ:MRNA technically setup for U-shape recovery and it has some positive news related to variants of the coronavirus in laboratory tests. The first resistance could be 169.
Disclaimer: I"m NOT a financial advisor. All trades idea are shared for educational purposes only. All advice is based on technical and my own opinion.
MRNA, Next Move 235ish Using measure move technique. NASDAQ:MRNA next resistance could be 235ish (166 + 66)
